In response to the crisis caused by COVID-19, Lilly is introducing the Lilly Insulin Value Program, allowing anyone with commercial insurance and those without insurance to fill their monthly prescription of Lilly insulin for $35. The program is effective today and covers most Lilly insulins. Details and more information can be found in their press release here: https://e.lilly/2wjEr7J.